AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.00
Bid: 48.00
Ask: 50.00
Change: -0.50 (-1.01%)
Spread: 2.00 (4.17%)
Open: 49.50
High: 49.00
Low: 48.00
Yest. Close: 49.50
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

OptiBiotix Health extends terms of licence agreement with OptiPharm

Wed, 5th Aug 2020 15:42

(Sharecast News) - Life sciences company OptiBiotix Health has extended the terms of its original exclusive licence agreement for 'OptiBiome' with OptiPharm, it said on Wednesday, which was initially announced on 31 March.
The AIM-traded firm said the terms of the exclusive licence agreement signed in March granted OptiPharm exclusive use of the OptiBiome trademark in Australia, parts of Asia, New Zealand, the Middle East, the Gulf states and North America.

It said the extension of terms now included Europe, with market exclusivity still linked to minimum order quantities.

OptiBiotix described OptiPharm as a privately owned Australian company, which has been operating for 24 years and specialises in weight management, nutrition and infant formula.

It said its products were produced in "state-of-the-art" Australian manufacturing facilities that are 'Good Manufacturing Practice' (GMP) qualified and 'Hazard Analysis and Critical Control Point' (HACCP) certified.

OptiPharm's flagship brand , Optislim, is the number one weight management brand in the Australian market, incorporating shakes, soups and bars available as total or partial meal replacements.

Optislim is used by consumers in Australia, New Zealand, China, shortly the Middle East and the United Arab Emirates, and was set for release throughout south east Asia, North America and Europe.

"We will shortly be releasing a new range of Optislim products which will include OptiBiotix's patented ingredient for weight management, and are delighted that OptiBiotix has agreed to an extension of terms that provides unrestricted access to additional international markets," said OptiPharm managing director Garry McDonald.

Dr Fred Narbel, managing director of OptiBiotix's prebiotics division, added that the company was "very pleased" with the extension of terms for OptiPharm, adding that it strengthened the commercial relationship between both companies.

"It is also another important commercial step in bringing OptiBiotix's patented and award-winning, scientifically formulated functional ingredients to global markets with Australia's number one weight management brand."

At 1307 BST, shares in OptiBiotix Health were down 3.27% at 53.2p.

More News

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

21 Apr 21 14:44

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

16 Apr 21 15:17

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

23 Mar 21 15:04

Optibiotix names René Kamminga as CEO of subsidiary

(Sharecast News) - Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.

23 Mar 21 08:06

OptiBiotix expands product ranges, sees positive drug trial results

OptiBiotix expands product ranges, sees positive drug trial results

17 Mar 21 15:50

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

18 Feb 21 11:13

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

2 Feb 21 14:38

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

19 Jan 21 16:30

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

11 Jan 21 17:29

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

5 Jan 21 17:55

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

9 Dec 20 16:08

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

18 Nov 20 14:53

OptiBiotix grants LPLDL licence to Canada's Genuine Health

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has granted a non-exclusive licence for 'LPLDL' to Genuine Health, for a cardiovascular health product in Canada and the United States.

18 Nov 20 12:23

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

12 Oct 20 14:34

OptiBiotix products launch into retail in Australia, New Zealand

(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.

12 Oct 20 14:00

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.